Posted On: 03/06/2014 5:27:26 PM
Post# of 63839
$BOTA climber $6.94
Shares outstanding of the registrant’s common stock,
par value $0.10 per share at February 10, 2014 was
35,060,911 shares
Biota Pharmaceuticals, Inc. to Present at the 26th Annual ROTH Conference
2/24/2014 4:33:00 PM - GlobeNewswire
Biota Pharmaceuticals Reports Second Quarter 2013 Financial Results and Recent Corporate Developments
2/10/2014 7:00:00 AM - GlobeNewswire
Biota Pharmaceuticals Inc. And Venaxis Inc.: 2 Upcoming Biopharmaceuticals Catalysts That Could Generate Big Gains
2/5/2014 8:32:00 AM - Seeking Alpha
Biota Pharmaceuticals to Host Conference Call to Report Second Quarter Financial Results on February 10, 2014
2/3/2014 9:00:00 AM - GlobeNewswire
Biota Announces Full Exercise of Over-Allotment Option
1/14/2014 7:00:00 AM - GlobeNewswire
Shares outstanding of the registrant’s common stock,
par value $0.10 per share at February 10, 2014 was
35,060,911 shares
Biota Pharmaceuticals, Inc. to Present at the 26th Annual ROTH Conference
2/24/2014 4:33:00 PM - GlobeNewswire
Biota Pharmaceuticals Reports Second Quarter 2013 Financial Results and Recent Corporate Developments
2/10/2014 7:00:00 AM - GlobeNewswire
Biota Pharmaceuticals Inc. And Venaxis Inc.: 2 Upcoming Biopharmaceuticals Catalysts That Could Generate Big Gains
2/5/2014 8:32:00 AM - Seeking Alpha
Biota Pharmaceuticals to Host Conference Call to Report Second Quarter Financial Results on February 10, 2014
2/3/2014 9:00:00 AM - GlobeNewswire
Biota Announces Full Exercise of Over-Allotment Option
1/14/2014 7:00:00 AM - GlobeNewswire
(0)
(0)
